Lördag 21 December | 19:25:28 Europe / Stockholm

Kalender

Tid*
2024-02-20 - Bokslutskommuniké 2023
2023-11-07 - Kvartalsrapport 2023-Q3
2023-08-18 - Kvartalsrapport 2023-Q2
2023-04-26 - X-dag ordinarie utdelning BIOS 0.00 SEK
2023-04-25 - Årsstämma
2023-04-25 - Kvartalsrapport 2023-Q1
2023-02-22 - Bokslutskommuniké 2022
2022-11-15 - Kvartalsrapport 2022-Q3
2022-09-19 - Extra Bolagsstämma 2022
2022-08-31 - Kvartalsrapport 2022-Q2
2022-05-04 - X-dag ordinarie utdelning BIOS 0.00 SEK
2022-05-03 - Årsstämma
2022-05-03 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-11-09 - Kvartalsrapport 2021-Q3
2021-08-12 - Kvartalsrapport 2021-Q2
2021-05-04 - Kvartalsrapport 2021-Q1
2021-04-20 - X-dag ordinarie utdelning BIOS 0.00 SEK
2021-04-19 - Årsstämma
2021-02-23 - Bokslutskommuniké 2020
2020-11-05 - Kvartalsrapport 2020-Q3
2020-08-18 - Kvartalsrapport 2020-Q2
2020-05-08 - X-dag ordinarie utdelning BIOS 0.00 SEK
2020-05-07 - Årsstämma
2020-05-07 - Kvartalsrapport 2020-Q1
2020-02-21 - Bokslutskommuniké 2019
2019-11-05 - Kvartalsrapport 2019-Q3
2019-09-10 - Extra Bolagsstämma 2019
2019-08-13 - Kvartalsrapport 2019-Q2
2019-05-10 - X-dag ordinarie utdelning BIOS 0.00 SEK
2019-05-06 - Årsstämma
2019-05-06 - Kvartalsrapport 2019-Q1
2019-02-19 - Bokslutskommuniké 2018
2018-11-06 - Kvartalsrapport 2018-Q3
2018-10-02 - Extra Bolagsstämma 2018
2018-08-24 - Kvartalsrapport 2018-Q2
2018-05-03 - X-dag ordinarie utdelning BIOS 0.00 SEK
2018-05-02 - Årsstämma
2018-05-02 - Kvartalsrapport 2018-Q1
2018-02-26 - Bokslutskommuniké 2017
2017-11-16 - Kvartalsrapport 2017-Q3
2017-08-17 - Kvartalsrapport 2017-Q2

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorIndustri
IndustriIndustriprodukter
Bioservo Technologies är ett teknikbolag inriktade mot hälsovårdssektorn. Bolaget utvecklar robotteknologi anpassat för personer som lider utav nedsatt muskelstyrka. Teknologin baseras på den framtagna SEM-teknologin (Soft Extra Muscle), som används för att hantera patientens uthållighet. Ett exempel är bolagets servohandske som är anpassad för personer med nedsatt funktion i händerna. Bolaget grundades 2006 och har sitt huvudkontor i Kista.
2023-12-14 11:16:07

An extraordinary general meeting was held in Bioservo Technologies AB (publ), below the "Company", on December 14, 2023. At the meeting, it was resolved that the Company should enter into voluntary liquidation. The decision was unanimous.

Decision on voluntary liquidation 
The extra general meeting adopted the proposal from the board of directors and thus resolved that the Company should enter into voluntary liquidation in accordance with Chapter 25, Section 3 of the Swedish Companies Act. 

Liquidation date
The resolution regarding liquidation will take effect from the date when the Swedish Companies Registration Office (Sw Bolagsverket) appoints a liquidator.

Estimated distribution date
The distribution of any liquidation proceeds will take place after the notice period for unknown creditors has expired, or - at the latest - in conjunction with the presentation of the liquidator's final report. The board of directors finds it challenging to provide anything more than a rough estimate regarding the distribution date, but, hopefully the distribution can take place during the third or fourth quarter of 2024.

Estimated distribution amount
The board's preliminary assessment is that the potential distribution to shareholders will amount to maximum SEK 5 million. However, also in this case, it is difficult to predict the size of the distribution amount, as it depends on both the costs associated with the business and liquidation process up to the distribution date, and the proceeds from the sale of the Company's assets.

Proposed liquidator 
Olov Kling, lawyer at Advokatfirman Lindahl, was proposed as liquidator.

Information to shareholders during the liquidation process
Information and announcements regarding the liquidation process will be published on the Company's website www.bioservo.com.

For more information, please contact
Petter Bäckgren, CEO, Bioservo Technologies AB
Phone: +468 21 17 10
petter.backgren@bioservo.com  (petter.backgren@bioservo.com )

Mikael Wester, Marketing Director, Bioservo Technologies AB
Phone: +468 21 17 10
mikael.wester@bioservo.com

About Bioservo Technologies
Bioservo Technologies AB (publ) is a world leading company in wearable muscle strengthening systems for people in need of extra strength and endurance. All our innovative products and systems are designed to keep people strong, healthy and efficient. The company has a unique global position within soft exoskeleton technology for the hand, both for industrial applications to improve the health for workers and to improve quality of life for people with reduced muscle strength. Bioservo Technologies was founded in 2006 in collaboration between researchers at the Royal Institute of Technology and a doctor at Karolinska University Hospital. Bioservo Technologies is a Swedish public limited company with headquarters in Kista north of Stockholm.

FNCA Sweden AB is the company's Certified Adviser on Nasdaq First North Growth Market.
For more information, please visit www.bioservo.com